7553.5000 -11.50 (-0.15%)
NSE Jul 04, 2025 15:31 PM
Volume: 349.1K
 

Prabhudas Lilladhar
to ensure non-compete and synergy alignment between AHEL and NewCo, with clear role demarcation - AHEL to focus on core healthcare and NewCo on pharmacy & digital. The demerger was on expected lines and is aimed to unlock value by creating a focused, high-growth platform in the pharmacy and digital healthcare space, which is more consumer centric in nature. The stake sale in HealthCo to Advent and merger with Keimed are a positive step and will lead to an integrated pharmacy distribution business. Scale-up in...
Apollo Hospitals Ent.. has an average target of 7660.40 from 5 brokers.
More from Apollo Hospitals Enterprise Ltd.
Recommended